{
  "drug_name": "Piperacillin-Tazobactam",
  "drug_id": "piperacillin_tazobactam",
  "generic_name": "piperacillin-tazobactam",
  "brand_names": ["Zosyn"],
  "class": "Extended-spectrum penicillin + Beta-lactamase inhibitor",
  "version": "3.0.0",
  "last_updated": "2025-10-08",

  "routes": ["IV"],
  "default_route": "IV",

  "contraindications": {
    "absolute": ["severe_pcn_allergy_with_anaphylaxis", "severe_pcn_allergy_with_sjs"],
    "relative": [],
    "note": "SAFE for mild PCN allergy (rash only). Avoid in severe allergy."
  },

  "allergy_considerations": {
    "mild_pcn_allergy": {
      "safe": true,
      "note": "Mild PCN allergy (rash only) CAN use piperacillin-tazobactam with caution",
      "evidence": "If no better alternative for critical infection, can be used carefully"
    },
    "severe_pcn_allergy": {
      "safe": false,
      "contraindicated": true,
      "note": "Absolute contraindication in anaphylaxis/SJS/DRESS. Use aztreonam instead."
    }
  },

  "pregnancy_category": "B",
  "pregnancy_safe": true,
  "pregnancy_notes": "Safe in pregnancy. Good option for intra-abdominal infections in pregnancy.",

  "renal_adjustment": {
    "required": true,
    "note": "Dose adjustment based on CrCl",
    "adjustments": {
      "crcl_gt_40": "3.375 g IV q6h OR 4.5 g IV q8h",
      "crcl_20_40": "2.25 g IV q6h",
      "crcl_lt_20": "2.25 g IV q8h",
      "dialysis": "2.25 g IV q8h + 0.75 g after each dialysis"
    }
  },

  "dosing": {
    "by_indication": {
      "pneumonia_hap_vap": {
        "dose": "4.5 g IV",
        "frequency": "q6h",
        "infusion": "extended infusion (4 hour) preferred",
        "duration": "7-14 days",
        "route": "IV",
        "note": "Higher dose for Pseudomonas coverage"
      },
      "intra_abdominal": {
        "dose": "3.375 g IV",
        "frequency": "q6h",
        "duration": "4-7 days (source control dependent)",
        "route": "IV",
        "note": "Has anaerobic coverage built-in"
      },
      "bacteremia": {
        "dose": "3.375-4.5 g IV",
        "frequency": "q6-8h",
        "duration": "14+ days",
        "route": "IV"
      },
      "pyelonephritis_complicated": {
        "dose": "3.375 g IV",
        "frequency": "q6h",
        "duration": "7-14 days",
        "route": "IV",
        "note": "For hospital-acquired or complicated pyelonephritis"
      },
      "ssti": {
        "dose": "3.375 g IV",
        "frequency": "q6h",
        "duration": "7-14 days",
        "route": "IV",
        "note": "For severe diabetic foot infections, necrotizing fasciitis, or polymicrobial SSTI"
      },
      "bone_joint": {
        "dose": "3.375 g IV",
        "frequency": "q6h",
        "duration": "4-6 weeks",
        "route": "IV",
        "note": "Prolonged therapy for osteomyelitis. Often combined with vancomycin for MRSA coverage."
      }
    }
  },

  "extended_infusion": {
    "recommended": true,
    "rationale": "Time-dependent killing. Extended infusion improves outcomes for Pseudomonas",
    "method": "Infuse over 4 hours instead of 30 minutes",
    "indications": ["Pseudomonas infection", "critically ill", "resistant organisms"]
  },

  "spectrum": {
    "gram_positive": "Good (including Strep, some Staph - not MRSA)",
    "gram_negative": "Excellent (including Pseudomonas)",
    "anaerobes": "Excellent",
    "atypicals": "No coverage",
    "critical_strength": "Broad-spectrum with Pseudomonas and anaerobic coverage"
  },

  "monitoring": {
    "required": ["renal function", "clinical response"],
    "optional": ["CBC (prolonged therapy)"]
  },

  "adverse_effects": {
    "common": ["diarrhea", "nausea", "injection site phlebitis"],
    "serious": ["C. difficile colitis", "neutropenia (prolonged therapy)"],
    "rare": ["interstitial nephritis", "seizures (high dose + renal failure)"]
  },

  "notes": [
    "Broad-spectrum antibiotic with Pseudomonas coverage",
    "Has built-in anaerobic coverage (tazobactam)",
    "Extended infusion preferred for critical illness",
    "Safe for mild PCN allergy (rash only)",
    "CONTRAINDICATED for severe PCN allergy",
    "Requires renal adjustment",
    "Safe in pregnancy"
  ],

  "evidence": [
    "IDSA HAP/VAP Guidelines",
    "IDSA Complicated Intra-Abdominal Infection Guidelines",
    "Extended infusion studies for Pseudomonas"
  ]
}
